Children’s Hospital Los Angeles clinicians and scientists are onsite at this year’s American Society of Pediatric Hematology/Oncology meeting, held from May 6-9.
Thomas D. Coates, MDSection Head of HematologyChildren’s Center for Cancer and Blood DiseasesChildren’s Hospital Los Angeles
Presentation: “Provocative Iron Overload Cases in Pediatric Hematology and Oncology”Wednesday, May 6, 7:45-9:15 pm
Our bodies usually keep our iron levels in check—the amount we absorb from food is about equal to the amount we need. However, patients who receive frequent blood transfusions, such as children with cancer or blood diseases, can take in too much iron for their bodies to handle. Called iron overload, this dangerous condition results in iron deposits around organs such as the heart, liver, and pancreas, where it can cause organ damage and failure.
Thomas D. Coates, MD, is available to discuss iron overload resulting from cancer, sickle cell disease, thalassemia and other diseases.
David R. Freyer, DO, MSDirector, Survivorship and Supportive Care ProgramDirector, LIFE Cancer Survivorship & Transition ServiceMember, Leukemia/Lymphoma Program of the Children’s Center for Cancer and Blood Diseases Children’s Hospital Los Angeles
Presentation: “Barriers to Treatment in AYAs: Treatment Toxicities”Saturday, May 9, noon- 1:30 pm
Over the past 30 years, adolescents and young adults (AYAs, 15-39 years old) with cancer have shown significantly lower improvement in survival compared with both younger and older patients. A possible cause for lower survival in AYAs is excessive treatment-related side effects, or “toxicity”, which can result in mortality, compromised cancer treatment, and reduced quality of life in these patients.
David R. Freyer, DO, MS, is available to discuss transition of care, psychosocial functioning, and the unique needs of AYA patients.
RSS